Short stature, obesity, and growth hormone deficiency in pseudohypoparathyroidism type 1a

Pediatric Endocrinology Reviews

Volumn 3, Issue SUPPL. 2, 2006, Pages 318-327

  Germain Lee, Emily L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Albright Hereditary Osteodystrophy; G Protein; GHRH Resistance; GNAS; Growth Hormone Deficiency; Pseudohypoparathyroidism

Indexed keywords

FOLLITROPIN; GLUCAGON; GROWTH HORMONE RELEASING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LUTEINIZING HORMONE; PARATHYROID HORMONE; RECOMBINANT GROWTH HORMONE; THYROTROPIN;

ADOLESCENT; ADULT; ALBRIGHT SYNDROME; ANTHROPOMETRY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEREDITY; HORMONAL THERAPY; HORMONE RESISTANCE; HUMAN; MALE; OBESITY; PREVALENCE; PROVOCATION TEST; PSEUDOHYPOPARATHYROIDISM; SHORT STATURE; STATISTICAL ANALYSIS;

BODY HEIGHT; DWARFISM; HUMAN GROWTH HORMONE; HUMANS; OBESITY; PSEUDOHYPOPARATHYROIDISM;

EID: 33646230544     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Germain-Lee EL, Groman J, Crane JL, Jan de Beur SM, Levine MA. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab 2003;88:4059-4069
2. Levine MA. Pseudohypoparathyroidism. In: Bilezikian JP, Raisz LG, Rodan GA (eds). San Diego: Principles of Bone Biology. Academic Press, 2002;1137-1163
3. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr Rev 2001;22:675-705
4. Bastepe M, Juppner H. GNAS locus and pseudohypoparathyroidism. Horm Res 2005;63:65-74
5. Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M. Minireview: GNAS: normal and abnormal functions. Endocrinology 2004;145:5459-5464
6. Bastepe M, Juppner H. Editorial: Pseudohypoparathyroidism and mechanisms of resistance toward multiple hormones: molecular evidence to clinical presentation. J Clin Endocrinol Metab 2003;88:4055-4058
7. Brickman AS, Carlson HE, Levin SR. Responses to glucagon infusion in pseudohypoparathyroidism. J Clin Endocrinol Metab 1986;63:1354-1360
8. Davies SJ, Hughes HE. Imprinting in Albright's hereditary osteodystrophy. J Med Genet 1993;30:101-103
9. Levine MA, Downs RW Jr, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 1983;74:545-556
10. Mantovani G, Maghnie M, Weber G, De Menis E, Brunelli V, Cappa M, Loli P, Beck-Peccoz P, Spada A. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type 1a: new evidence for imprinting of the Gsα gene. J Clin Endocrinol Metab 2003;88:4070-4074
11. Albright F, Burnett CH, Smith PH. Pseudohypoparathyroidism: an example of "Seabright-Bantam syndrome." Endocrinology 1942;30:922-932
12. Albright F, Forbes AP, Henneman PH. Pseudopseudohypoparathyroidis m. Trans Assoc Am Physicians 1952;65:337-350
13. Wilson LC, Trembath RC. Albright's hereditary osteodystrophy. [Review]. J Med Genet 1994;31:779-784
14. Hayward BE, Moran V, Strain L, Bonthron DT. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci U S A 1998;95:15475-15480
15. Hayward BE, Kamiya M, Strain L, Moran V, Campbell R, Hayashizaki Y, Bonthron DT. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci U S A 1998;95:10038-10043
16. Swaroop A, Agarwal N, Gruen JR, Bick D, Weissman SM. Differential expression of novel Gsα signal transduction protein cDNA species. Nucleic Acids Research 1991;17:4725-4729
17. Kehlenbach RH, Matthey J, Huttner WB. XLαs is a new type of G protein. Nature 1994;372:804-808
18. Klemke M, Pasolli HA, Kehlenbach RH, Offermanns S, Schultz G, Huttner WB. Characterization of the extra-large G protein alpha-subunit XLαs. II. Signal transduction properties. J Biol Chem 2000;275:33633-33640
19. Pasolli HA, Klemke M, Kehlenbach RH, Wang Y, Huttner WB. Characterization of the extra-large G protein alpha -subunit XLαs. I. Tissue distribution and subcellular localization. J Biol Chem 2000;275:33622-33632
20. Ischia R, Lovisetti-Scamihorn P, Hogue-Angeletti R, Wolkersdorfer M, Winkler H, Fischer-Colbrie R. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem 1997;272:11657-11662
21. Leitner B, Lovisetti-Scamihorn P, Heilmann J, Striessnig J, Blakely RD, Eiden LE, Winkler H. Subcellular localization of chromogranins, calcium channels, amine carriers, and proteins of the exocytotic machinery in bovine splenic nerve. J Neurochem 1999;72:1110-1116
22. Plagge A, Isles AR, Gordon E, Humby T, Dean W, Gritsch S, Fischer-Colbrie R, Wilkinson LS, Kelsey G. Imprinted Nesp55 influences behavioral reactivity to novel environments. Mol Cell Biol 2005;25:3019-3026
23. Jan de Beur S, Ding C, Germain-Lee E, Cho J, Maret A, Levine MA. Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1. Am J Hum Genet 2003;73:314-322
24. Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG, Weinstein LS. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest 2000;106:1167-1174
25. Liu J, Chen M, Deng C, Bourc'his D, Nealon JG, Erlichman B, Bestor TH, Weinstein LS. Identification of the control region for tissue-specific imprinting of the stimulatory G protein α-subunit. Proc Natl Acad Sci U S A 2005;102:5513-5518
26. Yu S, Yu D, Lee E, Eckhaus M, Lee R, Corria I, Accili D, Westphal H, Weinstein LS. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsα) knockout mice is due to tissue-specific imprinting of the Gsα gene. Proc Natl Acad Sci U S A 1998;95:8715-8720
27. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein LS, Juppner H. Receptor-mediated adenylyl cyclase activation through XLα(s), the extra-large variant of the stimulatory G protein α-subunit. Mol Endocrinol 2002;16:1912-1919
28. Germain-Lee EL, Schwindinger W, Crane JL, Zewdu R, Zweifel LS, Wand G, Huso DL, Saji M, Ringel MD, Levine MA. A mouse model of Albright Hereditary Osteodystrophy generated by targeted disruption of exon 1 of the GNAS gene. Endocrinology 2005;146:4697-4709
29. Chen M, Gavrilova O, Liu J, Xie T, Deng C, Nguyen AT, Nackers LM, Lorenzo J, Shen L, Weinstein LS. Alternative GNAS gene products have opposite effects on glucose and lipid metabolism. Proc Natl Acad Sci U S A 2005;102:7386-7391
30. s in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 2002;296:67-72
31. Hayward BE, Barlier A, Korbonits M, Grossman AB, Jacquet P, Enjalbert A, Bonthron DT. Imprinting of the G(s)α gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 2001;107:R31-R36
32. Liu J, Erlichman B, Weinstein LS. The stimulatory G protein alpha-subunit Gsα is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metab 2003;88:4336-4341
33. s gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 2002;87:4736-4740
34. Hayward BE, Bonthron DT. An imprinted antisense transcript at the human GNAS1 locus. Hum Mol Genet 2000;9:835-841
35. Faull CM, Welbury RR, Paul B, Kendall-Taylor P. Pseudohypoparath yroidism: its phenotypic variability and associated disorders in a large family. Q J Med 1991;78:251-264
36. Marguet C, Mallet E, Basuyau JP, Martin D, Leroy M, Brunelle P. Clinical and biological heterogeneity in pseudohypoparathyroidism syndrome. Results of a multicenter study. Horm Res 1997;48:120-130
37. Scott DC, Hung W. Pseudohypoparathyroidism type Ia and growth hormone deficiency in two siblings. J Pediatr Endocrinol Metab 1995;8:205-207
38. Shima M, Nose O, Shimizu K, Seino Y, Yabuuchi H, Saito T. Multiple associated endocrine abnormalities in a patient with pseudohypoparathyroidism type 1a. Eur J Pediatr 1988;147:536-538
39. Suzuki H, Kasai K, Shimoda S, Mori K, Miyasaka M. Improvement in abnormal secretion of thyrotropin and gonadotropin after restoration of serum calcium in pseudohypoparathyroidism. Endocrinol Jpn 1982;29:69-75
40. Urdanivia E, Mataverde A, Cohen MP. Growth hormone secretion and sulfation factor activity in pseudohypoparathyroidism. J Lab Clin Med 1975;86:772-776
41. Wagar G, Lehtivuori J, Salven I, Backman R, Sivula A. Pseudohypoparathyroidism associated with hypercalcitoninaemia. Acta Endocrinol (Copenh) 1980;93:43-48
42. Steinbach HL, Young DA. The roentgen appearance of pseudohypoparathyroidism (PH) and pseudo-pseudohypoparathyroidism (PPH). Differentiation from other syndromes associated with short metacarpals, metatarsals, and phalanges. Am J Roentgenol Radium Ther Nucl Med 1966;97:49-66
43. AACE medical guidelines for clinical practice for growth hormone use in adults and children, 2003 update. Endocr Pract 2003;9:64-76
44. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res 2001;11:137-165
45. Allen D, Kleinberg D, Biller B, Cuneo R, Bengtsson B-A, Melmed S, Blethen S, Hintz R. The diagnosis and management of adult hormone deficiency. Clinical Courier 1998;16:1-12
46. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996;81:3323-3327
47. Maghnie M, Cavigioli F, Tinelli C, Autelli M, Arico M, Aimaretti G, Ghigo E. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. J Clin Endocrinol Metab 2002;87:2740-2744
48. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998;83:1615-1618
49. Pavlou M, Tsatsoulis A, Efstathiadou Z, Bitsis S, Papadopoulou ZL. A study of the growth-promoting and metabolic effects of growth hormone (GH) in a patient with the "growth without GH" syndrome. Growth Horm IGF Res 2001;11:225-230
50. Blethen SL, Weldon VV. Outcome in children with normal growth following removal of a craniopharyngioma. Am J Med Sci 1986;292:21-24
51. Bucher H, Zapf J, Torresani T, Prader A, Froesch ER, Illig R. Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. N Engl J Med 1983;309:1142-1146
52. Costin G, Kogut MD, Phillips LS, Daughaday WH. Craniopharyngioma: the role of insulin in promoting postoperative growth. J Clin Endocrinol Metab 1976;42:370-379
53. Pinto G, Bussieres L, Recasens C, Souberbielle JC, Zerah M, Brauner R. Hormonal factors influencing weight and growth pattern in craniopharyngioma. Horm Res 2000;53:163-169
54. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994;125:29-35
55. Bao XL, Shi YF, Du YC, Liu R, Deng JY, Gao SM. Prevalence of growth hormone deficiency of children in Beijing. Chin Med J (Engl) 1992;105:401-405
56. de Mel T, Warnasooriya N, Fonseka C. Growth hormone deficiency in Sri Lanka: a preliminary study. Ceylon Med J 1991;36:95-97
57. Tani N. [Epidemiologic study of dwarfism in Niigata Prefecture]. Nippon Naibunpi Gakkai Zasshi 1985;61:1295-1309
58. Vimpani GV, Vimpani AF, Lidgard GP, Cameron EH, Farquhar JW. Prevalence of severe growth hormone deficiency. Br Med J 1977;2:427-430
59. Aldred MA, Trembath RC. Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat 2000;16:183-189
60. Bastepe M, Weinstein LS, Ogata N, Kawaguchi H, Juppner H, Kronenberg HM, Chung UI. Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc Natl Acad Sci U S A 2004;101:14794-14799
61. Kobayashi T, Chung UI, Schipani E, Starbuck M, Karsenty G, Katagiri T, Goad DL, Lanske B, Kronenberg HM. PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development 2002;129:2977-2986
62. Sakamoto A, Chen M, Kobayashi T, Kronenberg HM, Weinstein LS. Chondrocyte-specific knockout of the G protein G(s)α leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation. J Bone Miner Res 2005;20:663-671
63. Tavella S, Biticchi R, Schito A, Minina E, Di Martino D, Pagano A, Vortkamp A, Horton WA, Cancedda R, Garofalo S. Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression. J Bone Miner Res 2004;19:1678-1688
64. van der Eerden BC, Karperien M, Gevers EF, Lowik CW, Wit JM. Expression of Indian hedgehog, parathyroid hormone-related protein, and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth. J Bone Miner Res 2000;15:1045-1055
65. Mantovani G, Bondioni S, Locatelli M, Pedroni C, Lania AG, Ferrante E, Filopanti M, Beck-Peccoz P, Spada A. Biallelic expression of the Gsα gene in human bone and adipose tissue. J Clin Endocrinol Metab 2004;89:6316-6319